Additionally, Skp2 inhibition maintains quiescence (Zhang et al., 2019) and suppresses tumor progression in multiple transgenic mouse models (Agarwal et al., 2008; Lin et al., 2010; Wang et al., 2010). The gene discussed is SKP2; the disease is neoplasm.